4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-030771
Senior Vice President and CFO sold 3,150 shares at $7.45 ($23,468)
- Senior Vice President and CFO acquired 3,150 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
STAAB THOMAS R II · Senior Vice President and CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-10-19 | Exercise or conversion : show line 1 in the form | +3,150 | $3.78 | $11,907 | 140,533 | D |
| 2018-10-19 | Sale : show line 2 in the form | −3,150 | $7.45 | $23,468 | 137,383 | D |
| Open-market sales · 3,150 sh · avg $7.45 · $23,468 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-10-19 | Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) | −3,150 | 49,305 | D |
Loading xslF345X03/form4.xml…